Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019‐nCoV Infection
Clinical Pharmacology & Therapeutics, 2020-08 [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1002/cpt.1844
Digital Resources/Online E-Resources